Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Ph IIA Study (SOC +/- NS5B)

ClinicalTrials.gov ID: NCT01193361

Public ClinicalTrials.gov record NCT01193361. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2A Study of BMS-791325 in Combination With Peg Interferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve Subjects With Chronic Hepatitis C Virus Genotype 1 Infection

Study identification

NCT ID
NCT01193361
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
39 participants

Conditions and interventions

Interventions

  • BMS-791325 Drug
  • Placebo Drug
  • Peg-interferon alfa-2a Drug
  • Ribavirin Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2010
Primary completion
May 31, 2011
Completion
Oct 31, 2012
Last update posted
Oct 8, 2015

2010 – 2012

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Advanced Clinical Research Institute Anaheim California 92801
Loyola University Medical Center Maywood Illinois 60153
Mercy Medical Center Baltimore Maryland 21202
Digestive Disease Associates, P.A. Baltimore Maryland 21229
Claudia T. Martorell, Md, Llc Springfield Massachusetts 01107
Charlotte Gastroenterology & Hepatology, Pllc Charlotte North Carolina 28207
Options Health Research, Llc Tulsa Oklahoma 74104
The North Texas Research Institute Arlington Texas 76012
Alamo Medical Research San Antonio Texas 78215
Metropolitan Research Fairfax Virginia 22031

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01193361, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2015 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01193361 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →